Quoin Pharmaceuticals Ltd. Treasury Stock, Common, Value
Quoin Pharmaceuticals Ltd. (QNRX) had Treasury Stock, Common, Value of $2.93 million as of 2023-09-30, per its 10-Q filed 2023-11-09.
Discontinued › Balance Sheet › Equity, Attributable to Parent
us-gaap:TreasuryStockCommonValue · last filed 2024-03-14
- 2023-09-30: Treasury Stock, Common, Value $2.93M.
- 2023-06-30: Treasury Stock, Common, Value $2.93M.
- 2023-03-31: Treasury Stock, Common, Value $2.93M.
- 2022-12-31: Treasury Stock, Common, Value $2.93M.
| Period end | Treasury Stock, Common, Value |
|---|---|
| 2023-09-30 | $2.93M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $2.93M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $2.93M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $2.93M 10-K · filed 2024-03-14 |
| 2022-09-30 | $2.93M 6-K · filed 2022-11-10 |
| 2022-06-30 | $2.93M 6-K · filed 2022-08-18 |
| 2021-12-31 | $2.93M 10-K · filed 2023-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 |